Primary Care

The approval provides a treatment option for adults and adolescents with warm autoimmune hemolytic anemia who are currently or were previously treated with corticosteroids.

In 2 phase 3 randomized, placebo-controlled trials of adults and adolescents with nonsegmental vitiligo, once-daily upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48...

Experts discuss how the 2025 ACC/AHA blood pressure guidelines may affect hypertension treatment decisions.

In this video, Brittany Albright, MD, discusses why primary care clinicians are often the first line of defense in recognizing and treating anxiety disorders. She reviews practical strategies for screening,...

Dr. William Schaffner, MD, reviews evolving adult vaccination guidance and key opportunities to prevent severe disease in clinical practice.

Two randomized, placebo-controlled studies evaluated treatment across the full spectrum of narcolepsy type 1 symptoms in adults.

Prediction models identified factors associated with concomitant and future psoriatic arthritis among patients with new-onset psoriasis.

The FDA approved the first-in-class targeted therapy based on a clinical trial evaluating overall survival among adults with previously treated metastatic pancreatic adenocarcinoma.

A US cohort study estimated chronic traumatic encephalopathy prevalence at death among former NFL players and its association with dementia.

At the August 2026 Practical Updates in Primary Care Virtual Meeting, Rakesh Jain, MD, MPH, and Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC, outlined a practical primary care approach to adult...